FDA Office of Training and Communication
Executive Summary
Regulatory Counsel John Friel named deputy director of the CDER office Dec. 10. Friel formerly addressed small business issues in the Office of the Commissioner and moved into OTCOM when the Commissioner's office was restructured in June (1"The Pink Sheet" June 28, p. 23). Friel replaces Linda Brophy, who departed OTCOM to serve as a special assistant to Office of Postmarketing Drug Risk Assessment Deputy Director Peter Honig, MD